Cargando…
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240055/ https://www.ncbi.nlm.nih.gov/pubmed/35764604 http://dx.doi.org/10.1038/s41408-022-00693-7 |
| _version_ | 1784737454806269952 |
|---|---|
| author | Zanwar, Saurabh Abeykoon, Jithma P. Dasari, Surendra Ravindran, Aishwarya Young, Jason R. Acosta-Medina, Aldo A. Rech, Karen L. Schwartz, Jonathan Mangold, Aaron Rosenthal, Allison Bennani, N. Nora Shah, Mithun V. Morlote, Diana Goyal, Gaurav Go, Ronald S. |
| author_facet | Zanwar, Saurabh Abeykoon, Jithma P. Dasari, Surendra Ravindran, Aishwarya Young, Jason R. Acosta-Medina, Aldo A. Rech, Karen L. Schwartz, Jonathan Mangold, Aaron Rosenthal, Allison Bennani, N. Nora Shah, Mithun V. Morlote, Diana Goyal, Gaurav Go, Ronald S. |
| author_sort | Zanwar, Saurabh |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9240055 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92400552022-06-30 Clinical and therapeutic implications of BRAF fusions in histiocytic disorders Zanwar, Saurabh Abeykoon, Jithma P. Dasari, Surendra Ravindran, Aishwarya Young, Jason R. Acosta-Medina, Aldo A. Rech, Karen L. Schwartz, Jonathan Mangold, Aaron Rosenthal, Allison Bennani, N. Nora Shah, Mithun V. Morlote, Diana Goyal, Gaurav Go, Ronald S. Blood Cancer J Correspondence Nature Publishing Group UK 2022-06-28 /pmc/articles/PMC9240055/ /pubmed/35764604 http://dx.doi.org/10.1038/s41408-022-00693-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Zanwar, Saurabh Abeykoon, Jithma P. Dasari, Surendra Ravindran, Aishwarya Young, Jason R. Acosta-Medina, Aldo A. Rech, Karen L. Schwartz, Jonathan Mangold, Aaron Rosenthal, Allison Bennani, N. Nora Shah, Mithun V. Morlote, Diana Goyal, Gaurav Go, Ronald S. Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title | Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title_full | Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title_fullStr | Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title_full_unstemmed | Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title_short | Clinical and therapeutic implications of BRAF fusions in histiocytic disorders |
| title_sort | clinical and therapeutic implications of braf fusions in histiocytic disorders |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240055/ https://www.ncbi.nlm.nih.gov/pubmed/35764604 http://dx.doi.org/10.1038/s41408-022-00693-7 |
| work_keys_str_mv | AT zanwarsaurabh clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT abeykoonjithmap clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT dasarisurendra clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT ravindranaishwarya clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT youngjasonr clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT acostamedinaaldoa clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT rechkarenl clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT schwartzjonathan clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT mangoldaaron clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT rosenthalallison clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT bennaninnora clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT shahmithunv clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT morlotediana clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT goyalgaurav clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders AT goronalds clinicalandtherapeuticimplicationsofbraffusionsinhistiocyticdisorders |